257 related articles for article (PubMed ID: 25712936)
1. Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease.
Zoccali C; London G
Nephrol Dial Transplant; 2015 Mar; 30(3):352-7. PubMed ID: 25712936
[TBL] [Abstract][Full Text] [Related]
2. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
Omata M; Fukagawa M; Kakuta T
Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
[TBL] [Abstract][Full Text] [Related]
3. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
4. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Bover J; Ureña-Torres P; Lloret MJ; Ruiz-García C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
Expert Opin Pharmacother; 2016 Jun; 17(9):1247-58. PubMed ID: 27156993
[TBL] [Abstract][Full Text] [Related]
5. Pro: cardiovascular calcifications are clinically relevant.
Bover J; Evenepoel P; Ureña-Torres P; Vervloet MG; Brandenburg V; Mazzaferro S; Covic A; Goldsmith D; Massy ZA; Cozzolino M;
Nephrol Dial Transplant; 2015 Mar; 30(3):345-51. PubMed ID: 25712934
[TBL] [Abstract][Full Text] [Related]
6. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M
J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706
[TBL] [Abstract][Full Text] [Related]
7. MICS, an easily ignored contributor to arterial calcification in CKD patients.
Zhang K; Gao J; Chen J; Liu X; Cai Q; Liu P; Huang H
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F663-F670. PubMed ID: 27335374
[TBL] [Abstract][Full Text] [Related]
8. Mineral metabolism and cardiovascular disease in CKD.
Fujii H; Joki N
Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
[TBL] [Abstract][Full Text] [Related]
9. [Vascular diseases in CKD-MBD].
Shioi A
Clin Calcium; 2016 Jun; 26(6):883-8. PubMed ID: 27230844
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Cardiovascular Markers in Chronic Kidney Disease.
Chen SC; Huang JC; Su HM; Chiu YW; Chang JM; Hwang SJ; Chen HC
Kidney Blood Press Res; 2018; 43(4):1388-1407. PubMed ID: 30153666
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications.
Bover J; Ureña-Torres P; Górriz JL; Lloret MJ; da Silva I; Ruiz-García C; Chang P; Rodríguez M; Ballarín J
Nefrologia; 2016; 36(6):597-608. PubMed ID: 27595517
[TBL] [Abstract][Full Text] [Related]
12. Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection?
Sakaguchi Y; Hamano T; Isaka Y
Adv Chronic Kidney Dis; 2018 May; 25(3):274-280. PubMed ID: 29793667
[TBL] [Abstract][Full Text] [Related]
13. Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.
Pruijm M; Lu Y; Megdiche F; Piskunowicz M; Milani B; Stuber M; Bachtler M; Vogt B; Burnier M; Pasch A
J Hypertens; 2017 Oct; 35(10):2044-2052. PubMed ID: 28562422
[TBL] [Abstract][Full Text] [Related]
14. Review article: Getting the balance right: assessing causes and extent of vascular calcification in chronic kidney disease.
Ketteler M; Biggar PH
Nephrology (Carlton); 2009 Jun; 14(4):389-94. PubMed ID: 19563380
[TBL] [Abstract][Full Text] [Related]
15. Detection of cardiovascular calcifications: Is it a useful tool for nephrologists?
Bover J; Górriz JL; Ureña-Torres P; Lloret MJ; Ruiz-García C; daSilva I; Chang P; Rodríguez M; Ballarín J
Nefrologia; 2016; 36(6):587-596. PubMed ID: 27575927
[TBL] [Abstract][Full Text] [Related]
16. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
Liabeuf S; Okazaki H; Desjardins L; Fliser D; Goldsmith D; Covic A; Wiecek A; Ortiz A; Martinez-Castelao A; Lindholm B; Suleymanlar G; Mallamaci F; Zoccali C; London G; Massy ZA
Nephrol Dial Transplant; 2014 Jul; 29(7):1275-84. PubMed ID: 24009287
[TBL] [Abstract][Full Text] [Related]
17. [Vascular calcification in chronic kidney disease].
Battaglia Y; Russo L; Asimakopoulos G; Storari A
G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030018
[TBL] [Abstract][Full Text] [Related]
18. [The prevention and treatment of vascular calcification.].
Kawakami K; Ohya M; Shigematsu T
Clin Calcium; 2019; 29(2):231-236. PubMed ID: 30679405
[TBL] [Abstract][Full Text] [Related]
19. A current understanding of vascular calcification in CKD.
Paloian NJ; Giachelli CM
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F891-900. PubMed ID: 25143458
[TBL] [Abstract][Full Text] [Related]
20. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
